168 related articles for article (PubMed ID: 37568715)
1. Identification of a Novel Eight-Gene Risk Model for Predicting Survival in Glioblastoma: A Comprehensive Bioinformatic Analysis.
Dang HH; Ta HDK; Nguyen TTT; Wang CY; Lee KH; Le NQK
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568715
[TBL] [Abstract][Full Text] [Related]
2. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Yin W; Tang G; Zhou Q; Cao Y; Li H; Fu X; Wu Z; Jiang X
Front Genet; 2019; 10():419. PubMed ID: 31130992
[TBL] [Abstract][Full Text] [Related]
3. Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma.
Zhang Y; Fan H; Zou C; Wei F; Sun J; Shang Y; Chen L; Wang X; Hu B
Front Genet; 2022; 13():924802. PubMed ID: 36035134
[TBL] [Abstract][Full Text] [Related]
4. A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses.
Cao M; Cai J; Yuan Y; Shi Y; Wu H; Liu Q; Yao Y; Chen L; Dang W; Zhang X; Xiao J; Yang K; He Z; Yao X; Cui Y; Zhang X; Bian X
Cancer Biol Med; 2019 Aug; 16(3):595-605. PubMed ID: 31565488
[TBL] [Abstract][Full Text] [Related]
5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
6. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
Lai W; Li D; Kuang J; Deng L; Lu Q
Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma.
Chen Y; Pan Y; Gao H; Yi Y; Qin S; Ma F; Zhou X; Guan M
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12315-12332. PubMed ID: 37432454
[TBL] [Abstract][Full Text] [Related]
9. Identification of Prognostic Biomarkers of Glioblastoma Based on Multidatabase Integration and Its Correlation with Immune-Infiltration Cells.
Ding W; Zhou X; Jiang G; Xu W; Long S; Xiao F; Liao Y; Liu J
J Oncol; 2022; 2022():3909030. PubMed ID: 35685428
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma.
Zhu W; Luo N; Li Q; Chen X; Li X; Fu M; Yang F; Chen Z; Zhang Y; Zhang Y; Peng X; Hu G
Ann Transl Med; 2023 Jan; 11(2):69. PubMed ID: 36819551
[TBL] [Abstract][Full Text] [Related]
11. Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma.
Cui G; Xiao Y
Autoimmunity; 2022 Sep; 55(6):418-427. PubMed ID: 35574600
[TBL] [Abstract][Full Text] [Related]
12. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
Prasad B; Tian Y; Li X
Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a cuproptosis-related prognostic model for glioblastoma.
Zhang B; Xie L; Liu J; Liu A; He M
Front Immunol; 2023; 14():1082974. PubMed ID: 36814929
[TBL] [Abstract][Full Text] [Related]
14. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
15. Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma.
Hou Z; Luo D; Luo H; Hui Q; Xu Y; Lin X; Xu Z
Ann Med; 2023 Dec; 55(1):778-792. PubMed ID: 36856519
[TBL] [Abstract][Full Text] [Related]
16. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
17. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma.
Ren W; Jin W; Liang Z
Front Neurol; 2022; 13():832944. PubMed ID: 35370869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]